Literature DB >> 10992294

Prediction of recurrence by microsatellite analysis in head and neck cancer.

I Sardi1, A Franchi, G Ferriero, A Frittelli, L Bruschini, E Montali, O Gallo.   

Abstract

We examined the possibility of using microsatellite alterations as markers to detect clonal tumor-derived cell populations in histopathologically negative surgical margins and cervical lymph nodes from head and neck cancer (HNC) patients. We used polymerase chain reaction (PCR)-based microsatellite analysis DNA to analyze primary tumors, paired surgical margins, and cervical lymph nodes from 41 HNC patients. Samples were scored for alterations as defined by the presence of new alleles (shifts) or loss of heterozygosity (LOH) at each of 10 markers. We identified 25 (61%) patients with primary HNC who appeared to have had a complete resection on the basis of the histopathological assessment and who were informative regarding microsatellite alterations in tumor tissue. In 11 of these 25 (44%) cases, PCR analysis of surgical margins showed the same microsatellite alterations as in the primary tumors. In 7 of these 11 patients, the carcinoma recurred locally, as compared with 1 out of 14 patients with negative margins (log rank test, P = 0.0049). Conversely, we were unable to detect clonal neoplastic cells in histopathologically negative lymph nodes examined by molecular analysis. Cox regression analysis showed that molecular positive margins were an independent prognostic factor (P = 0.04) for recurrence. This study demonstrates that microsatellite analysis may be a valuable tool for evaluating the risk of local recurrence. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10992294     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1031>3.0.co;2-x

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

Review 1.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

Review 2.  Molecular margins in head and neck cancer: Current techniques and future directions.

Authors:  Katelyn O Stepan; Michael M Li; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-07-20       Impact factor: 5.337

3.  Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.

Authors:  Jong-Lyel Roh; William H Westra; Joseph A Califano; David Sidransky; Wayne M Koch
Journal:  Head Neck       Date:  2012-01-03       Impact factor: 3.147

Review 4.  Oral premalignancy: the roles of early detection and chemoprevention.

Authors:  Jean-Philippe Foy; Chloé Bertolus; William N William; Pierre Saintigny
Journal:  Otolaryngol Clin North Am       Date:  2013-05-25       Impact factor: 3.346

Review 5.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment.

Authors:  Sara I Pai; William H Westra
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 6.  DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.

Authors:  Yu Chen; Chu Chen
Journal:  Head Neck       Date:  2008-10       Impact factor: 3.147

Review 7.  Postoperative pathologic assessment of surgical margins in oral cancer: A contemporary review.

Authors:  Arpan K Shah
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

8.  Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.

Authors:  Claus Wittekindt; Steffen Wagner; Christina Sabine Mayer; Jens Peter Klussmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

9.  Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas.

Authors:  H K Tan; P Saulnier; A Auperin; L Lacroix; O Casiraghi; F Janot; P Fouret; S Temam
Journal:  Br J Cancer       Date:  2008-07-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.